Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Rabin

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Annals of Internal Medicine|November 20, 2008
ADVANTAGE: Merck does say "no"Alexander Rabin
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 23, 2017
Comparison of extracorporeal photopheresis and alemtuzumab for the treatment of chronic lung allograft dysfunctionAnna Moniodis, Keri Townsend, Alexander Rabin, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Annals of Internal Medicine|November 20, 2008
ADVANTAGE: Merck does say "no"Alexander Rabin
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 23, 2017
Comparison of extracorporeal photopheresis and alemtuzumab for the treatment of chronic lung allograft dysfunctionAnna Moniodis, Keri Townsend, Alexander Rabin, et al.
Pageof 1